Stem Point Capital LP Fulcrum Therapeutics, Inc. Call Options Transaction History
Stem Point Capital LP
- $378 Billion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding FULC
# of Institutions
136Shares Held
44.2MCall Options Held
3.12MPut Options Held
128K-
Rtw Investments, LP New York, NY5.85MShares$49.3 Million0.89% of portfolio
-
Cowen And Company, LLC3.71MShares$31.3 Million1.18% of portfolio
-
Suvretta Capital Management, LLC New York, NY2.85MShares$24 Million1.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.54MShares$21.4 Million0.0% of portfolio
-
Trv Gp Iv, LLC Boston, MA2.34MShares$19.8 Million10.72% of portfolio
About Fulcrum Therapeutics, Inc.
- Ticker FULC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,038,900
- Market Cap $439M
- Description
- Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...